Stay updated on Durvalumab + Tremelumab in LS-SCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab + Tremelumab in LS-SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab + Tremelumab in LS-SCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page’s footer shows an updated ClinicalTrials.gov revision from v3.5.2 to v3.5.3, indicating a software/version update rather than any substantive modification to the study’s record history.
    Difference
    0.1%
    Check dated 2026-04-24T06:30:42.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and Deleted Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:49:11.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T08:33:18.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added a new site revision entry (v3.4.3) and removed the previous revision entry (v3.4.2) in the page's version history.
    Difference
    0.1%
    Check dated 2026-03-12T02:43:02.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added, and the Notice about government funding and the prior Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:26:33.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding and NIH Clinical Center operating status. Updated the history page to Revision: v3.4.1 and removed the v3.4.0 reference. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:36:21.000Z thumbnail image

Stay in the know with updates to Durvalumab + Tremelumab in LS-SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab + Tremelumab in LS-SCLC Clinical Trial page.